Progyny IncPGNY
Price$24.85Intrinsic value$45.7384% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $45.73median of 6 methods · middle span $35-$237based on filings through 30 Jun 2026
Market Price $24.85Price as of 1 Oct 2026
Margin of Safety +84.0%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 11.2% (near-term consensus, capped) · years 2–5: 45.6%/yr (balance of the path).38.0% per year
Years 6–10: glide to demonstrated growth own history 27.8%, capped at 20%
Per-year rates
Yr 640.5%Yr 735.4%Yr 830.2%Yr 925.1%Yr 1020.0%
45.6% → 20.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1118.3%Yr 1216.6%Yr 1314.9%Yr 1413.2%Yr 1511.5%Yr 169.8%Yr 178.1%Yr 186.4%Yr 194.7%Yr 203.0%
20.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 2 windows (5/7y) (limited history)27.8%
Discount rate (cost of equity) 9.5%
Volatility vs market (adjusted beta)1.01

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetProgyny IncPGNYHealth Care
Valuation
P/E27.0×
P/S1.6×
P/B5.2×
EV / Revenue1.5×
EV / EBITDA8.2×
Profitability
Gross margin25.3%
Operating margin10.8%
Net margin6.0%
FCF margin13.6%
Returns
ROE17.3%
ROA11.0%
ROIC26.2%
Growth
Revenue growth (YoY)12.3%
5-yr fwd EPS growth38.0%
Financial strength
Debt / Equity0.00×
Current ratio2.14×
Altman Z-Score7.9
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.